Antibodies to heteromeric glycolipid complexes in guillain-barré syndrome

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Rinaldi, Simon ^a   Brennan, Kathryn M ^a   Kalna, Gabriela ^b   Walgaard, Christa ^c   Van Doorn, Pieter ^c   Jacobs, Bart C ^c   Yu, Robert K ^d   Mansson, Jan Eric ^e   Goodyear, Carl S ^a   Willison, Hugh J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GANGLIOSIDE; GLYCOLIPID; IMMUNOGLOBULIN G ANTIBODY; SULFATIDE;

ADOLESCENT; ADULT; AGED; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; ARTIFICIAL VENTILATION; BINDING AFFINITY; CAMPYLOBACTER ENTERITIS; CHILD; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE SEVERITY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; WESTERN EUROPE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CHILD; FEMALE; GANGLIOSIDES; GLYCOLIPIDS; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84892728445     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082337     Document Type: Article

References (33)

1. Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S et al. (2007) Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci27(15): 3956-3967. doi:10.1523/JNEUROSCI.4401-06.2007. PubMed: 17428969.
2. Yuki N (2007) Ganglioside mimicry and peripheral nerve disease. Muscle and Nerve35(6): 691-711. doi:10.1002/mus.20762.
3. Goodyear CS, O'Hanlon GM, Plomp JJ, Wagner ER, Morrison I et al. (1999) Monoclonal antibodies raised against Guillain-Barre syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J-Clin-Invest 104: 697-708.
4. Halstead SK, O'Hanlon GM, Humphreys PD, Morrison DB, Morgan BP et al. (2004) Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain 127: 2109-2123. doi:10.1093/brain/awh231. PubMed: 15289269.
5. Rinaldi S, Willison HJ (2008) Ganglioside antibodies and neuropathies. Curr Opin Neurol 21: 540-546. PubMed: 18769247.
6. Willison HJ (2007) Gangliosides as targets for autoimmune injury to the nervous system. J Neurochem103 Suppl 1: 143-149. doi:10.1111/j. 1471-4159.2007.04718.x. PubMed: 17986149.
7. Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27 Suppl: S21-S24. doi:10.1002/ana.410270707. PubMed: 2194422.
8. Van der Meche FG, Van Doorn PA, Meulstee J, Jennekens FG (2001) Diagnostic and classification criteria for the Guillain-Barre syndrome. Eur-Neurol 45: 133-139.
9. Svennerholm L, Boström K, Fredman P, Jungbjer B, Lekman A et al. (1994) Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord. Biochim Biophys Acta 1214: 115-123. PubMed: 7918590.
10. Nores GA, Lardone RD, Comín R, Alaniz ME, Moyano AL et al. (2008) Anti-GM1 antibodies as a model of the immune response to self-glycans. Biochim Biophys Acta 1780: 538-545. PubMed: 18029096.
11. Buchwald B, Zhang G, Vogt-Eisele AK, Zhang W, Ahangari R et al. (2007) Anti-ganglioside antibodies alter presynaptic release and calcium influx. Neurobiol Dis28(1): 113-121. doi:10.1016/j.nbd. 2007.07.008. PubMed: 17720506.
12. Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K et al. (2004) Ganglioside complexes as new target antigens in Guillain-Barre syndrome. Ann-Neurol 56: 567-571.
13. Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, et al. (2007) Anti-ganglioside complex antibodies associated with severe disability in GBS. JNeuroimmunol 182: 212-218
14. Varki A (1994) Selectin ligands. Proc-Natl-Acad-Sci-U-S-A 91: 7390-7397. doi:10.1073/pnas.91.16.7390.
15. Greenshields KN, Halstead SK, Zitman FM, Rinaldi S, Brennan KM et al. (2009) The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. J Clin Invest 119: 595-610. PubMed: 19221437.
16. Zitman FMP, Greenshields KN, Kuijf ML, Ueda M, Kaida K et al. (2011) Neuropathophysiological potential of Guillain-Barré syndrome anti-ganglioside-complex antibodies at mouse motor nerve terminals. Clinical and Experimental. Journal of Neuroimmunology 2: 59-67. doi: 10.1111/j.1759-1961. 2011.00022.x.
17. Rinaldi S, Brennan KM, Goodyear CS, O'Leary C, Schiavo G et al. (2009) Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. Glycobiology 19: 789-796. doi:10.1093/glycob/cwp049. PubMed: 19349623.
18. Rinaldi S, Brennan KM, Willison HJ (2010) Heteromeric glycolipid complexes as modulators of autoantibody and lectin binding. Prog Lipid Res 49: 87-95. doi:10.1016/j.plipres.2009.09.001. PubMed: 19735674.
19. Mori K, Mahmood MI, Neya S, Matsuzaki K, Hoshino T (2012) Formation of GM1 ganglioside clusters on the lipid membrane containing sphingomyeline and cholesterol. J Phys Chem B 116: 5111-5121. doi:10.1021/jp207881k. PubMed: 22494278.
20. DeMarco ML (2012) Three-dimensional structure of glycolipids in biological membranes. Biochemistry 51: 5725-5732. doi:10.1021/bi3003633. PubMed: 22794115.
21. Van Koningsveld R, Schmitz PI, Meché FG, Visser LH, Meulstee J et al. (2004) Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barre syndrome: randomised trial. Lancet 363: 192-196. doi:10.1016/S0140-6736(03)15324-X. PubMed: 14738791.
22. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2: 750-753. PubMed: 80682.
23. Brennan KM, Galban-Horcajo F, Rinaldi S, O'Leary CP, Goodyear CS et al. (2011) Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis. J Neuroimmunol 238: 87-95. doi:10.1016/j.jneuroim. 2011.08.002. PubMed: 21872346.
24. Hadden RDM, Cornblath DR, Hughes RaC, Zielasek J, Hartung H-P et al. (1998) Electrophysiological classification of guillain-barré syndrome: Clinical associations and outcome. Ann Neurol 44: 780-788. doi: 10.1002/ana.410440512. PubMed: 9818934.
25. Kuijf ML, Van Doorn PA, Tio-Gillen AP, Geleijns K, Ang CW et al. (2005) Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA. J Neurol Sci 239: 37-44. doi:10.1016/j.jns.2005.07.009. PubMed: 16154154.
26. Rinaldi S, Brennan KM, Willison HJ (2012) Combinatorial glycoarray. Methods Mol Biol 808: 413-423. doi:10.1007/978-1-61779-373-8-28. PubMed: 22057541.
27. Yu RK, Yoshino H, Yamawaki M, Yoshino JE, Ariga T (1994) Subcellular Distribution of Sulfated Glucuronyl Glycolipids in Human Peripheral Motor and Sensory Nerves. J Biomed Sci 1: 167-171. PubMed: 11725022.
28. Li YT, Månsson JE, Vanier MT, Svennerholm L (1973) Structure of the major glucosamine-containing ganglioside of human tissues. J Biol Chem 248: 2634-2636. PubMed: 4698234.
29. Jones CM, Athanasiou T (2005) Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg 79: 16-20. doi:10.1016/j.athoracsur. 2004.09.040. PubMed: 15620907.
30. Uncini A, Manzoli C, Notturno F, Capasso M (2010) Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes. J Neurol Neurosurg Psychiatry 81: 1157-1163. doi:10.1136/jnnp.2010.208538. PubMed: 20870864.
31. Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M et al. (2000) Axonal Guillain-Barre syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann-Neurol 48: 624-631.
32. McGonigal R, Rowan EG, Greenshields KN, Halstead SK, Humphreys PD et al. (2010) Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain 133: 1944-1960. doi:10.1093/brain/awq119. PubMed: 20513658.
33. Jacobs BC (2012) IGOS - International GSB Outcome Study | About IGOS. IGOS. Available: https://www.gbsstudies.org/about-igos. Accessed 24 September 2012